Financial News
SciSparc Ltd. - Ordinary Shares (NQ: SPRC )
0.6165
-0.0265
(-4.12%)
Streaming Delayed Price
Updated: 10:57 AM EDT, Jul 22, 2024
Add to My Watchlist
Headline News about SciSparc Ltd. - Ordinary Shares
![](https://cdn.benzinga.com/files/images/story/2024/07/16/Charles-Schwab-shutter.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2024/05/pltr1600-6-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2024/07/obesity1600.png)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/13/scisparc_stock_sprc_shares_ai-generated-8245187_1280.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/07/11/Movers.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/16/image49.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/16/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/11/fastenal_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Business-Partnership-Meeting-Concept--Im_17.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/11/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/testalize-me-9xHsWmh3m-4-unsplash.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/peter-burdon-C2zX9DEVSDs-unsplash.jpeg?width=1200&height=800&fit=crop)
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
March 08, 2024
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/images/story/2024/Psyched_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/psychedelic-chemistry-geralt-by-pixabay_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/psychpatents.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/fractal-1680252-1280.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/20/fluor_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Psyched-New---option-1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/24/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/24/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/cannabis-pharmaceutical-pot-stock.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/24/image23.jpeg?width=1200&height=800&fit=crop)
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales
January 24, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2023/12/cmnd1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/13/image15_0.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2023/12/cmnd1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/04/psyched.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.